Alvotech • ALVO
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Mark Levick$3.8B
Market Cap • 24/04/20242018
(há 6 anos)
2022
(2 years ago)
NASDAQ
Listagem
Luxembourg
858
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ALVOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.